Search results
Results from the WOW.Com Content Network
Fluticasone propionate, sold under the brand names Flovent and Flonase among others, is a glucocorticoid steroid medication. [8] When inhaled it is used for the long term management of asthma and COPD. [8] In the nose it is used for hay fever and nasal polyps. [9] [10] It can also be used for mouth ulcers. [11] It works by decreasing inflammation.
Original file (1,275 × 1,650 pixels, file size: 173 KB, MIME type: application/pdf, 2 pages) This is a file from the Wikimedia Commons . Information from its description page there is shown below.
Studies have demonstrated the safety of inhaled fluticasone propionate in children. A systematic review published in 2013 found no significant adverse effect on the function of the hypothalamic–pituitary–adrenal axis , growth, and bone mineral density in asthmatic children when inhaled fluticasone is used for up to three months.
Short title: 2018 Form 1040: Image title: U.S. Individual Income Tax Return: Author: SE:W:CAR:MP: Keywords: Fillable: Software used: Adobe LiveCycle Designer ES 9.0
As of the 2018 tax year, Form 1040, U.S. Individual Income Tax Return, is the only form used for personal (individual) federal income tax returns filed with the IRS. In prior years, it had been one of three forms (1040 [the "Long Form"], 1040A [the "Short Form"] and 1040EZ – see below for explanations of each) used for such returns.
The original Form 1040, available on the IRS website as well as elsewhere, is three pages [59] and 31 lines long, with the first page focused on computing one's income tax, the second page focused on more detailed documentation of one's income and the third page describing deductions and including a signature area. There is an additional page ...
Fluticasone is a manufactured glucocorticoid used to treat nasal congestion. [1] [2] [3] [4] [5] Both the esters, fluticasone propionate (sold as Flovent) and ...
The following is a list of WHO recommended strains for the Northern Hemisphere influenza season. Starting in the 2012–2013 season, the recommendation shifted to include the composition of a quadrivalent influenza vaccine (QIV) that contains both influenza B lineages, alongside a trivalent influenza vaccine (TIV) containing one influenza B lineage.